The Latest: Shkreli jury ends day 1 of deliberations

FILE - In this Thursday, July 27, 2017, file photo, former biotech CEO Martin Shkreli, center, leaves federal court with his attorney Benjamin Brafman, left, in New York. A jury began deliberations Monday, July 31, 2017, at Shkreli's federal securities fraud trial. (AP Photo/Julie Jacobson, File)

NEW YORK — The Latest in the federal securities fraud trial of former pharmaceutical CEO Martin Shkreli (all times local):

5:45 p.m.

Jurors in New York have finished their first day of deliberations in the federal securities fraud trial of former pharmaceutical CEO Martin Shkreli (SHKREL'-ee) without reaching a verdict.

They are expected back on Tuesday to continue deliberating on the charges he faces.

Prosecutors say Shkreli looted his drug company to pay back investors in two failed hedge funds he ran. The defense says investors got their original investments back and even made hefty profits.

The former biotech CEO is best known for hiking up the price of a life-saving drug and for trolling his critics on social media.

If convicted of the most serious counts he could face up to 20 years in prison but likely would receive far less time under sentencing guidelines.

___

10:30 a.m.

Jurors are deliberating in the federal securities fraud trial of former pharmaceutical CEO Martin Shkreli (SHKREL'-ee).

They got the case Monday in New York.

On Friday, they heard closing arguments by prosecutors accusing Shkreli of looting his own drug company to pay back disgruntled investors in two failed hedge funds he ran.

The defense insisted there were no victims because everyone got their original investments back and even made hefty profits.

The 34-year-old Shkreli is best known for jacking up the price of a life-saving drug by 5,000 percent and for trolling his critics online.

___

7:04 a.m.

The federal securities fraud trial of former pharmaceutical CEO Martin Shkreli (SHKREL'-ee) is moving toward the decision-making phase.

Jurors could start deliberating Monday at the trial in New York.

On Friday, they heard closing arguments by prosecutors accusing Shkreli of looting his own drug company to pay back disgruntled investors in two failed hedge funds he ran.

The defense insisted there were no victims because everyone got their original investments back and even made hefty profits.

The 34-year-old Shkreli is best known for jacking up the price of a life-saving drug by 5,000 percent and for trolling his critics online.

Must Read

A Minneapolis-area Prince pilgrimage a year after his death

Apr 5, 2017

Fans of the late music icon Prince looking to pay homage on the first anniversary of his death will want to seek out sites around his Minneapolis area home base

Defense lawyer calls witness at FIFA bribery trial 'liar'

Nov 18, 2017

Lawyer for South American soccer official charged in corruption case involving the sport's governing body calls key witness at New York trial 'serial liar'

Exhibition explores African design as agent of change

Oct 12, 2017

An exhibition opening in Atlanta encourages visitors to look at Africa through new eyes

People also read these

A Minneapolis-area Prince pilgrimage a year after his death

Apr 5, 2017

Fans of the late music icon Prince looking to pay homage on the first anniversary of his death will want to seek out sites around his Minneapolis area home base

Defense lawyer calls witness at FIFA bribery trial 'liar'

Nov 18, 2017

Lawyer for South American soccer official charged in corruption case involving the sport's governing body calls key witness at New York trial 'serial liar'

Exhibition explores African design as agent of change

Oct 12, 2017

An exhibition opening in Atlanta encourages visitors to look at Africa through new eyes